Posts

Class C Medical Device Import License in India – MD-14, MD-15, MDR 2017 & CDSCO Approval Guide

Class C Medical Device Import License in India Common Mistakes Under MDR 2017 — Practically Explained By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | Founder – RegIntel Med India Importing a Class C medical device in India is not just an application. It is a regulatory strategy decision. Under the Medical Device Rules (MDR) 2017 , Class C devices fall under moderate-to-high risk, meaning: Your documentation depth increases CDSCO scrutiny intensifies Approval timelines expand Query handling becomes critical Most delays in Class C import license applications (MD-14 / MD-15) happen due to preventable strategic mistakes. This article explains those mistakes practically — not just legally. Why Class C Import Applications Face Higher Scrutiny For Class C medical device import in India: ✔ Application is filed in Form MD-14 ✔ License is granted in Form MD-15 ✔ Device Master File (DMF) is mandatory ✔ Plant Master File (PMF) is required ✔ Indian Authorized Agent is co...
Post a Comment
Read more

ISO 13485 for Medical Device Startups in India – What Actually Matters Under MDR 2017

ISO 13485 for Medical Device Startups What Actually Matters (And What Doesn’t) By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Most medical device startups misunderstand ISO 13485. They treat it as: A certificate to obtain A compliance checkbox A consultant-driven documentation exercise But ISO 13485 is not a certificate. It is a system for building controlled, traceable, defensible medical devices . And for startups operating under MDR 2017 in India , it is not optional thinking. Why ISO 13485 Matters for Startups Even if you are early-stage, ISO 13485 influences: Regulatory approval timelines CDSCO confidence Investor trust Product consistency Risk management maturity ⚠️ Common Founder Mistake Waiting until “just before submission” to implement ISO 13485. By then, design decisions are already undocumented. What ISO 13485 Is (Practically) ISO 13485 is a Quality Management System (QMS) standard tailored for medical devices. ...
Post a Comment
Read more

How to Classify Medical Devices in India (Class A, B, C & D) – MDR 2017 Guide

Medical Device Classification in India Class A, B, C & D — Practically Explained Under MDR 2017 By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Medical device classification in India is not paperwork. It is the single decision that determines: Your regulatory pathway Your documentation burden Your clinical evidence requirements Your approval timelines Your compliance cost Under the Medical Device Rules (MDR), 2017 , every medical device is classified into Class A, B, C, or D based on risk. Misclassify your device — and everything downstream becomes unstable. This article explains classification practically , not just legally. Why Classification Matters More Than You Think Your classification affects: Whether you apply to State or Central authority Which forms you submit (MD-5, MD-9, MD-14, etc.) Whether clinical investigation is required How intense CDSCO scrutiny will be Post-market obligations ⚠️ Common Founder Mistake...
Post a Comment
Read more

Why CDSCO Rejects Medical Device Applications in India

Why CDSCO Rejects Medical Device Applications in India The Real Reasons — And How to Avoid Costly Delays By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Medical device applications in India are not rejected randomly. They are rejected predictably. Most rejections under the Medical Device Rules (MDR) 2017 are not due to technological flaws or innovation gaps. They occur because of documentation inconsistency, regulatory misinterpretation, or process discipline failures . Understanding why CDSCO rejects applications is not about fear — it is about preparation. This article explains the real scrutiny patterns , the most common rejection triggers, and how serious teams avoid them. Why This Matters A rejected application can: Delay market entry by months Trigger costly rework Block customs clearance Damage regulatory credibility Increase investor anxiety Most of this is preventable. The Most Common Reasons CDSCO Rejects Applicati...
Post a Comment
Read more

A Practical Roadmap for Developing Medical Devices in India

A Practical Roadmap for Developing Medical Devices in India From Idea to Market — Without Costly Regulatory Mistakes By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Developing a medical device in India is not just an engineering challenge. It is a regulatory, clinical, manufacturing, and ethical journey — and most failures happen not because the product is bad, but because the roadmap is wrong . Too many teams build first and think about regulation later. By the time CDSCO enters the picture, timelines are already broken. This guide lays out a clear, India-specific roadmap for medical device development — grounded in MDR 2017, CDSCO scrutiny patterns, and real-world failures — so teams can build right , not just fast. Why This Matters An incorrect development sequence can: Delay approvals by months Multiply compliance costs Force redesigns late in the lifecycle Undermine regulatory credibility Most of this is preventable —...
Post a Comment
Read more

Why CDSCO Rejects MD-14 Import License Applications — Real Reasons + How to Avoid Rejection

Why CDSCO Rejects MD-14 Import License Applications — Real Reasons + How to Avoid Rejection  By Ankur K. Khare – Biomedical Engineer |  Regulatory Affairs Specialist   |   AI Ethics & Medical Innovation Form MD-14 rejection by CDSCO is one of the most common regulatory bottlenecks for medical device importers in India. Based on real scrutiny patterns, this article explains the top MD-14 rejection reasons and how to avoid them. Importing medical devices into India legally requires approval under Form MD-14 , followed by grant of an import license in Form MD-15 from the Central Drugs Standard Control Organization (CDSCO). When done correctly, this license enables legal customs clearance and distribution of devices across India. However, a surprisingly high number of MD-14 applications are rejected at the CDSCO scrutiny stage , leading to delays, increased costs, and supply disruptions for manufacturers and importers. Understanding the real reasons behi...
Post a Comment
Read more

MDR 2017 Made Simple: Chapter XII – Miscellaneous & Transitional Provisions (Part 12 of 12)

MDR 2017 Made Simple: Chapter XII – Miscellaneous & Transitional Provisions (Part 12 of 12) By Ankur K. Khare – Biomedical Engineer | AI Ethics & Medical Innovation Welcome to Part 12! You’ve reached the final part of the MDR 2017 Made Simple series. In this chapter, we bring together the “miscellaneous” and transitional provisions that quietly shape how MDR 2017 works in real life—old licenses, exemptions, record‑keeping, renewals, and how these rules connect to the future of device regulation in India. These aren’t flashy topics, but they decide whether your existing approvals stay valid, how you migrate to new formats, and how safe you are when rules evolve. Perfect for founders, regulatory professionals, and biomedical engineers who want long‑term regulatory stability, not just one‑time approvals. 1. Transitional Provisions: Moving from Old to New When MDR 2017 came into force, India already had devices approved under the older Drugs and Cosmetics Rules. Transiti...
Post a Comment
Read more